Qure AI | AI assistance for Accelerated Healthcare

Qure.ai is a healthcare technology company that leverages advanced deep learning algorithms to provide AI-powered assistance for the analysis of medical imaging, primarily in radiology. Its core mission is to make expert-level diagnostic support accessible, affordable, and timely for healthcare professionals worldwide, thereby accelerating clinical workflows and improving patient outcomes. The platform acts as a virtual assistant, interpreting scans to flag abnormalities and prioritize critical cases, which is especially valuable in resource-constrained settings.

Key features: The tool offers a suite of FDA-cleared and CE-marked algorithms for specific anatomical regions and conditions. For instance, its qXR solution automatically detects and localizes over 30 findings on chest X-rays, including tuberculosis, lung cancer, and pneumothorax. The qCT brain module assists in the rapid triage of head CT scans for stroke, hemorrhage, and fractures. Other capabilities include qMSK for musculoskeletal X-rays and algorithms for cardiac and pediatric applications, all designed to integrate into existing PACS and hospital workflows to provide real-time, quantitative results.

What sets Qure.ai apart is its strong focus on global health and deployment in low- and middle-income countries (LMICs), where radiologist shortages are acute. The technology is built to work with standard DICOM images and is validated across diverse populations and imaging equipment. It emphasizes high sensitivity to avoid missed diagnoses and offers cloud-based, on-premise, or edge deployment options. The company also provides robust clinical validation studies and regulatory clearances, ensuring its tools meet stringent medical device standards for safe clinical use.

Ideal for radiologists, pulmonologists, emergency department physicians, and healthcare administrators in hospitals, clinics, and screening programs. Specific use cases include mass TB screening in public health initiatives, rapid triage of stroke patients in emergency rooms, early detection of lung nodules in oncology workflows, and supporting remote diagnostics in telemedicine networks. It is also valuable for private imaging centers seeking to enhance report accuracy and throughput.

The platform operates on a freemium model, with basic screening tools potentially available for free in certain public health contexts, while comprehensive enterprise solutions for hospitals involve custom pricing based on modules, volume, and deployment scale, typically starting in the range of thousands of dollars annually.